GLP-1 Weight Loss Programme Online in Europe: Supervision and Costs
What a doctor-supervised GLP-1 weight loss programme in Europe should include, from eligibility and labs to dose titration, plus how costs split.
A safe GLP-1 weight loss programme online in Europe should include an eligibility check (a BMI of 30 or more, or 27 or more with a weight-related condition), a full medical assessment, baseline blood tests, scheduled follow-ups during each dose increase and responsive side-effect support. Costs come in two parts: consultation or programme fees, and the medication itself, which is usually priced separately.
Who is eligible for GLP-1 weight loss treatment
GLP-1 medicines such as semaglutide and tirzepatide (sold for weight management under brand names including Wegovy and Mounjaro) are licensed in the EU for adults who meet clear criteria. A responsible prescriber will check these before anything else.
The standard thresholds are:
- BMI of 30 or above, or
- BMI of 27 or above with at least one weight-related condition, such as high blood pressure, type 2 diabetes or prediabetes, abnormal cholesterol, obstructive sleep apnoea or cardiovascular disease
If a service offers a prescription without verifying your height, weight and medical history, treat that as a warning sign. Eligibility is a safety measure, not a formality.
What the initial assessment should cover
The first consultation is where a doctor decides whether GLP-1 treatment is appropriate and safe for you. Online, this should still be a genuine clinical review rather than a tick-box questionnaire.
A thorough initial assessment includes:
- Weight history: previous attempts, patterns and any recent rapid changes
- Medical history: heart, kidney, liver and gallbladder conditions, diabetes and past pancreatitis
- Contraindications: personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2, pregnancy, plans to conceive and breastfeeding
- Current medicines: especially insulin or other glucose-lowering drugs, which can raise the risk of low blood sugar when combined with GLP-1 treatment
- Eating behaviour screening: a history of eating disorders needs careful consideration before starting an appetite-suppressing medicine
- Lifestyle and goals: diet, activity, sleep and realistic expectations
The doctor should also explain how the medicine works. GLP-1 drugs mimic gut hormones that slow stomach emptying and act on appetite centres in the brain, so you feel full sooner and for longer. Understanding this helps you anticipate side effects and adjust how you eat.
Dose titration and follow-up
GLP-1 medicines are started at a low dose and increased gradually, typically every four weeks, until a maintenance dose is reached. This slow climb gives the digestive system time to adapt and reduces nausea and other gastrointestinal effects.
Good supervision means a check-in before each dose increase, not just a repeat prescription sent automatically. At each step, the doctor should review:
- Weight change and progress towards your goals
- Side effects and how well you are tolerating the current dose
- Food intake, particularly protein and fluids
- Whether to increase, hold or reduce the dose
Not everyone needs the highest dose. Some people do well on a lower maintenance dose, and a good clinician will tailor titration to your response rather than following a fixed schedule.
Side-effect support and safety
Most side effects are digestive and tend to be worst in the days after starting or increasing a dose. Common ones include nausea, vomiting, diarrhoea, constipation, bloating and reduced appetite to the point of under-eating.
A supervised programme should give you a clear way to report problems between appointments and practical advice on managing them, such as eating smaller meals, stopping when full and staying well hydrated. Less common but more serious risks include pancreatitis, gallbladder problems and dehydration that can affect kidney function.
You should be told which symptoms need urgent in-person care. Severe, persistent abdominal pain, especially if it spreads to the back, or being unable to keep fluids down, needs prompt medical attention. Online services are not emergency services, so you should always know when to contact local emergency care instead.
Rapid weight loss can also mean losing muscle as well as fat. Supervision should include guidance on adequate protein intake and resistance exercise to protect muscle mass.
Blood tests and monitoring
Baseline blood tests help confirm that treatment is safe and give a reference point for measuring health improvements, not just weight loss. Depending on your history, a doctor may request:
- HbA1c and fasting glucose to check for diabetes or prediabetes
- Kidney function, since dehydration from side effects can strain the kidneys
- Liver function, relevant for fatty liver disease, which often improves with weight loss
- Lipid profile to assess cardiovascular risk
- Thyroid function where symptoms or history suggest it
Repeat testing at intervals shows whether blood sugar, cholesterol and liver markers are improving. Blood pressure should also be tracked, as it often falls with weight loss and may mean other medicines need adjusting.
Comparing supervision options
Not every route to GLP-1 treatment offers the same level of care. The table below compares what to look for.
| Criterion | Well-supervised online programme | Prescription-only online service | Traditional in-person care |
|---|---|---|---|
| Eligibility check (BMI 30, or 27 with a condition) | Verified with medical history | Often self-reported only | Verified, measured in clinic |
| Initial assessment | Full clinical review with a doctor | Questionnaire, limited doctor contact | Full review, may involve a waiting list |
| Dose titration follow-ups | Review before each dose increase | Often automatic repeat prescriptions | Regular, but appointment availability varies |
| Side-effect support | Clear contact route between visits | Minimal or none | Available, often via general practice |
| Labs | Baseline and follow-up tests | Rarely requested | Usually arranged locally |
| Cost split | Consultation fees plus separate medication | Often bundled, less transparent | Varies by country and insurance |
How the costs split: consultations versus medication
When comparing programmes, separate the cost of medical supervision from the cost of the medicine. Bundled prices can hide how much care you are actually receiving.
At AETHERA Health, an EU-regulated online doctor platform based in Portugal, plans are priced as follows:
- Start: EUR 49/month
- Care: EUR 149/month
- Premium: EUR 299/month
Medication is billed separately and is not included in these plan prices. GLP-1 medication costs vary by product, dose and country, and we do not quote specific medication prices here. Reimbursement for weight management also differs across EU member states, so it is worth checking what applies where you live.
AETHERA serves residents of all 27 EU member states, with consultations in English, Portuguese, Spanish and French. Weight management, including GLP-1 medication where appropriate, is delivered by EU-registered, credential-verified physicians.
Where online care fits alongside your GP
Telehealth works best as a complement to your usual doctor, not a replacement. Online follow-ups make frequent titration reviews easier to fit into daily life, while your GP or local services remain important for physical examinations, local blood draws and urgent problems.
Sharing your treatment details with your regular doctor helps keep your records joined up, particularly if you take other medicines or have long-term conditions.
Frequently asked questions
Can I get a GLP-1 prescription online in Europe?
Yes, if you meet the eligibility criteria and a licensed doctor judges treatment appropriate after assessing your history. In the EU, this generally means a BMI of 30 or more, or 27 or more with a weight-related condition. Prescription and dispensing rules vary between member states, so check the arrangements in your country.
How often should I speak to a doctor during GLP-1 treatment?
During titration, a review before each dose increase is good practice, which is typically every four weeks. Once you reach a stable maintenance dose, check-ins may become less frequent. You should also be able to contact the clinical team between scheduled appointments if side effects or concerns arise.
Is medication included in AETHERA plan prices?
No. AETHERA plans cost EUR 49, EUR 149 or EUR 299 per month, and medication is billed separately. The cost of GLP-1 medication depends on the product, dose and country, so it is not included in the plan fee and no fixed medication price applies across the EU.
Do I need blood tests before starting a GLP-1 medicine?
Baseline blood tests are strongly advisable. They help rule out problems that could make treatment unsafe and provide a reference for tracking improvements. Common tests include HbA1c, kidney and liver function and cholesterol. Your doctor will decide which are relevant based on your medical history.
What happens if I stop taking a GLP-1 medicine?
Appetite usually returns as the medicine leaves your system, and many people regain some weight. This is why lifestyle changes in diet, activity and sleep matter throughout treatment. Any decision to stop or reduce your dose should be made with your doctor, who can plan a supported transition.
This article is for general information only. Please consult a licensed physician for personal medical advice.
About AETHERA Health
AETHERA Health is an EU-licensed telehealth platform founded and clinically led by Hilaryano Ferreira, cardiologist and co-author of peer-reviewed research on AI in remote cardiac care. Every diagnosis, prescription and clinical decision on the platform is made by a licensed physician.
Related articles
Ready to take control of your health?
Get matched with an EU-licensed physician in minutes.
Start Free Assessment